Research Output 1981 2020

Filter
Letter
2013
3 Citations (Scopus)

Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis

Moonan, P. K. & Weis, S. E., 1 Oct 2013, In : Clinical Infectious Diseases. 57, 7, p. 1062-1063 2 p.

Research output: Contribution to journalLetter

Directly Observed Therapy
Bacterial Drug Resistance
Antitubercular Agents
Mycobacterium tuberculosis
Meta-Analysis
2010

An accurate, objective test for minimal hepatic encephalopathy may provide a medical basis to prevent driving while encephalopathic

Cappell, M. S. & Gorrepati, N., 1 Nov 2010, In : Digestive Diseases and Sciences. 55, 11, p. 3294-3295 2 p.

Research output: Contribution to journalLetter

Automobile Driving
Hepatic Encephalopathy
Traffic Accidents
Patient Compliance
2 Citations (Scopus)

Measuring health-related quality of life in tuberculosis: A systemic review - Response

Weis, S. E. & Pasipanodya, J. G., 19 Jan 2010, In : Health and Quality of Life Outcomes. 8, 7.

Research output: Contribution to journalLetter

Psychometrics
Health Status
Tuberculosis
Quality of Life
2008
2 Citations (Scopus)

Assessing the impact of targeted tuberculosis interventions

Moonan, P. K. & Weis, S., 1 Mar 2008, In : American Journal of Respiratory and Critical Care Medicine. 177, 5, p. 557-558 2 p.

Research output: Contribution to journalLetter

Mobile Health Units
Mass Screening
Pulmonary Tuberculosis
Mycobacterium tuberculosis
Cluster Analysis
2005
7 Citations (Scopus)

Comprehensive cost description of tuberculosis care [2] (multiple letters)

Weis, S., Miller, T. L., Hilsenrath, P. E., Moonan, P. K., Rajbhandary, S. S., Marks, S. M. & Bock, N. N., 1 Apr 2005, In : International Journal of Tuberculosis and Lung Disease. 9, 4, p. 467-469 3 p.

Research output: Contribution to journalLetter

Multidrug-Resistant Tuberculosis
Cost Savings
Tuberculosis
Costs and Cost Analysis

Grass roots efforts: Can they make a difference? [1]

Knebl, J., 1 Jan 2005, In : Journal of the American Medical Directors Association. 6, 3, 1 p.

Research output: Contribution to journalLetter

Lobbying
Liability Insurance
State Government
Legal Liability
Policy Making
27 Citations (Scopus)

Improvement in tardive dyskinesia with aripiprazole use [7]

Witschy, J. K. & Winter, A. S., Mar 2005, In : Canadian Journal of Psychiatry. 50, 3, 1 p.

Research output: Contribution to journalLetter

Drug-Induced Dyskinesia
Piperazines
Risperidone
Quinolones
Valproic Acid
1999
7 Citations (Scopus)

Coronary events with lipid-lowering therapy: The AFCAPS/TexCAPS trial [1] (multiple letters)

Haq, I. U., Wallis, E. J., Yeo, W. W., Jackson, P. R., Ramsay, I. E., Krut, L. H., Kandzari, D. E., Goldschmidt-Clermont, P. J., Mason, J. M., Freemantle, N., McDiarmid, T. D., Hensel, W. A., Papadakis, J. A., Mikhailidis, D. P., Walsh, J., Sigel, D., Swislocki, A. L. M., Downs, J. R., Gotto, J., Clearfield, M. & 3 others, Weis, S., Rosenson, R. S. & Tangney, C. C., 3 Feb 1999, In : Journal of the American Medical Association. 281, 5, p. 414-419 6 p.

Research output: Contribution to journalLetter

Anticholesteremic Agents
Lovastatin
Coronary Disease
Lipids
Therapeutics